BNC Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,184
Closed -$910K 103
2023
Q1
$910K Buy
+18,184
New +$857K 0.51% 56
2022
Q1
Sell
-24,157
Closed -$1.03M 126
2021
Q4
$1.03M Buy
24,157
+1,112
+5% +$46.7K 0.49% 55
2021
Q3
$1M Buy
23,045
+1,343
+6% +$59.4K 0.59% 51
2021
Q2
$928K Buy
+21,702
New +$913K 0.56% 50
2020
Q4
Sell
-453
Closed -$17K 147
2020
Q3
$17K Buy
+453
New +$17.5K 0.01% 246

Other funds holding BSX

BNC Wealth Management's BSX Position: Q2 2023 in Review

BNC Wealth Management sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 18,184 shares — an estimated $910K sold.

BNC Wealth Management first reported a position in BSX in Q3 2020 and held it in 5 quarters. The position peaked at $1.03M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • BNC Wealth Management reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • BNC Wealth Management sold 18,184 Boston Scientific shares in Q2 2023, an estimated $910K.
  • BNC Wealth Management first reported a position in Boston Scientific in Q3 2020 and held it in 5 quarters.
  • BNC Wealth Management's Boston Scientific position peaked at $1.03M in Q4 2021.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on BNC Wealth Management's 13F filing for Q2 2023, filed 28 Jul 2023.